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For decades, aging was considered the inevitable result of the accumulation of damaged
macromolecules due to environmental factors and intrinsic processes. Our current knowl-
edge clearly supports that aging is a complex biological process inﬂuenced by multiple
evolutionary conserved molecular pathways.With the advanced age, loss of cellular home-
ostasis severely affects the structure and function of various tissues, especially those
highly sensitive to stressful conditions like the central nervous system. In this regard, the
age-related regression of neural circuits and the consequent poor neuronal plasticity have
been associated with metabolic dysfunctions, in which the decline of mitochondrial activity
signiﬁcantly contributes. Interestingly, while mitochondrial lesions promote the onset of
degenerative disorders, mild mitochondrial manipulations delay some of the age-related
phenotypes and, more importantly, increase the lifespan of organisms ranging from inver-
tebrates to mammals. Here, we survey the insulin/IGF-1 and the TOR signaling pathways
and reviewhow these two important longevity determinants regulatemitochondrial activity.
Furthermore, we discuss the contribution of slight mitochondrial dysfunction in the engage-
ment of pro-longevity processes and the opposite role of strong mitochondrial dysfunction
in neurodegeneration.
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INTRODUCTION
Eukaryotic cells have adopted an elaborated set ofmolecularmech-
anisms that prevent the accumulation of aberrantmacromolecules
(Kirkwood, 2005; Douglas and Dillin, 2010; Kourtis and Tav-
ernarakis, 2011). Over time, these protective responses decline
and make cells more vulnerable to stressful conditions. The con-
sequent dysfunction of tissues and organs can prompt to the
development of pathologies that compromise survival. For many
years, the age-related decline was considered simply a passive and
inevitable process. Conversely, it is now clear that aging is a biolog-
ical process, which like many others is subjected to the regulation
of well-deﬁned signaling pathways (Kenyon, 2010; Bano et al.,
2011; Martin, 2011). Most of these molecular cascades control
metabolism, proliferation, stress resistance, and cell maintenance.
Although their contribution to longevity was ﬁrstly described in
simple model organisms with a relatively short lifespan, like yeast
and invertebrates, a large number of ﬁndings inmammals support
that they are evolutionary conserved and likely relevant in humans
(Fontana et al., 2010).
Aging has a signiﬁcant impact in our modern human society,
as it is associated with the increased susceptibility to patholo-
gies. Intensive studies in the last years have shown that most of
the mechanisms involved in longevity inﬂuence also the onset of
sporadic forms of brain disorders (Mattson, 2006; Mattson and
Magnus, 2006; Bishop et al., 2010). The complex network of inter-
actions intimately links various signaling pathways and molecular
players that, together, contribute to such neurological conditions.
Among them, mitochondria have a fundamental role in neu-
ronal function and decline in their activity accelerates the onset
and progression of age-related dysfunction (Nunnari and Suo-
malainen, 2012; Rugarli and Langer, 2012). Interestingly, while
mild mitochondrial impairment extends the lifespan in various
organisms as different as yeast, invertebrates and mice, signiﬁ-
cant suppression of mitochondrial activity compromises animal
survival. Similarly, whilst mitochondrial deﬁciency or uncou-
pling can partially delay neuronal degeneration as a result of
excitotoxic injury or toxins, loss-of-function mutations in genes
encoding certain mitochondrial proteins can negatively disturb
neural circuits and ultimately lead to cell death. Here, we review
the advances in understanding some of themolecularmechanisms
that regulate certain aspects of aging, such as age-related mortal-
ity. We also dedicate particular attention to the contribution of
mitochondria to the signaling pathways involved in this impor-
tant biological process. Moreover, we address the controversial
opposite role of mitochondrial dysfunction in the onset of brain
pathologies.
LONGEVITY PATHWAYS
THE INSULIN/IGF-1 SIGNALING PATHWAY
The insulin/IGF-1 signaling pathway is one of the main path-
ways regulating aging in organisms ranging from invertebrates,
like Drosophila melanogaster and Caenorhabditis elegans, to mam-
mals. The role of this pathway in longevity was initially identiﬁed
in the nematode C. elegans through the discovery of mutants
that decrease the activity of the pathway and extend the lifes-
pan of the organism (Kenyon et al., 1993). The existence of such
mutations supported the concept of molecular factors underly-
ing aging. Among them, mutations in the gene age-1 extend the
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chronological lifespan of the nematode (Friedman and Johnson,
1988). This gene encodes the C. elegans ortholog of the class I
phosphoinositide 3-kinase (PI3K) and is a key enzyme in the
Insulin/IGF-1 signaling pathway. It catalyzes the production of
phosphatidylinositol-3,4,5-trisphosphate (Morris et al., 1996) that
serves as a second messenger for the activation of downstream
kinases. AGE-1/PI3K is activated by the sole insulin/IGF-1 recep-
tor DAF-2, which belongs to the tyrosine kinase receptor family
and is a master regulator of metabolism. Mutations in the daf-2
gene almost double the lifespanof nematodes (Kenyon et al., 1993),
mainly through the activation of the transcription factors DAF-
16/FOXO, SKN-1/Nrf, and HSF-1 (Hsu et al., 2003; Tullet et al.,
2008; Figure 1). In animals with reduced insulin/IGF-1 signal-
ing, the nuclear translocation of DAF-16/FOXO, SKN-1/Nrf, and
HSF-1 promotes the expression of various target genes involved
in stress resistance, proteostasis, defense reaction and metabolism
(Narasimhan et al., 2009). Interestingly, enhanced transcription
in certain tissues contributes differently to the aging of somatic
tissues. For example, speciﬁc expression of daf-16 in the intes-
tine – the main adipose tissue in nematodes – extends the lifespan
of daf-16; daf-2 double mutants, although it is not sufﬁcient
to completely restore the same survival as in the daf-2 mutant
animals (Libina et al., 2003). Notably, the activity in one tissue,
like in the case of the intestine, can regulate DAF-16-mediated
longevity pathways in others in a feedback loop that controls
post-mitotic cell senescence (Murphy et al., 2007). In this con-
text, the intestinal DAF-16/FOXO coordinates the rate of aging
of the whole organism in response to signals from the repro-
ductive and nervous systems. Block of germ cell proliferation in
animals lacking functional gonad increases the lifespan through
the DAF-16/FOXO accumulation in the intestinal nuclei and the
consequent gene transcription (Lin et al., 2001; Arantes-Oliveira
et al., 2002). Remarkably, loss-of-function of the microRNA mir-
71 in the nervous system suppresses intestinal DAF-16-dependent
gene expression and therefore germline-mediated longevity (Bou-
lias and Horvitz, 2012), further underlying the complexity of the
signals that dictate how long an organism is going to live.
The prominent role of the insulin/IGF-1 signaling pathway
in longevity is evolutionary conserved across species. In D.
melanogaster, mutations in the sole insulin/IGF-1 receptor (dINS)
or the insulin receptor substrate chico extend the lifespan through
the activation of the FOXO transcription factor (Clancy et al.,
2001; Tatar et al., 2001; Slack et al., 2011). Similarly to nematodes,
FOXO overexpression in the fat body is sufﬁcient to increase the
lifespan of ﬂies (Giannakou et al., 2004; Hwangbo et al., 2004).
In mice, haploinsufﬁciency of the insulin-like growth factor type
1 receptor (Igf1r) signiﬁcantly increases the lifespan compared
with wild-type littermates (Holzenberger et al., 2003). Although
the recent ﬁndings argue the increased longevity of Igf1r-deﬁcient
mice (Bokov et al., 2011), it is accepted that mild reduction of the
insulin/IGF-1 signaling throughout the body or even restricted
at the central nervous system can increase the lifespan of mice
(Taguchi et al., 2007). Even in humans, accumulating evidence
suggests that lower insulin/IGF-1 signaling is beneﬁcial for longer
survival (vanHeemst et al., 2005). It is noteworthy tomention that
single nucleotide polymorphisms in FOXO3A gene are strongly
associated with human longevity (Willcox et al., 2008). Likewise, a
study on centenarians demonstrated that heterozygous mutations
in the highly polymorphic Igf1r are correlated with longevity in
humans (Suh et al., 2008).
Decreased activity of the insulin/IGF-1 signaling pathway
enhances the resistance to exogenous and endogenous oxida-
tive stress in nematodes as well as in mice (Holzenberger et al.,
2003; Hsu et al., 2003). This is the result of the DAF-16/FOXO
reprogramming process and the consequent synthesis of chap-
erones and other anti-oxidant factors. Recent evidence suggests
that mitochondria are also important for the resistance of daf-
2 mutant nematodes through the production of reactive oxygen
species (ROS). ROS are a by-product of oxidative phosphory-
lation but apart from their toxic effect in high concentrations,
they can also act as signaling molecules. At least in nematodes,
impairment of the insulin/IGF-1 pathway increasesmitochondrial
activity and, as a consequence, ROS production. ROS mediate a
retrograde response resulting to up-regulation of genes encoding
antioxidant enzymes. Importantly, AMP-activated protein kinase
(AMPK) is required to sense the intracellular energetic status
associated with enhanced oxidative stress. As a result, AMPK
up-regulates L-proline mitochondrial catabolism while reduces
glucose metabolism, further contributing to the ROS genera-
tion (Ristow and Zarse, 2010; Zarse et al., 2012). In parallel,
while AMPK controls mitochondrial respiration in impaired glu-
cose conditions, SKN-1(Nrf) and PMK-1(p38) up-regulate the
transcription of speciﬁc genes and induce the protective stress
resistance response. Clearly, AMPK is a fundamental intracellular
checkpoint as it adapts intracellular metabolism and catabolism
to the energetic needs of the organism. In C. elegans, AMPK is
required for the extension of lifespan in mutants with reduced
insulin/ IGF-1 signaling, as it controls the lipid storage and the fat
metabolism according to the energetic stress (Apfeld et al., 2004;
Curtis et al., 2006; Narbonne and Roy, 2009). Overexpression of
the AMP-activated protein kinase subunit AAK-2 prolongs the
lifespan of the organism, whereas its loss-of-function reduces it
(Apfeld et al., 2004). Notably, AMPK deﬁciency compromises the
rapid mobilization of fat reservoirs, leading to premature lethal-
ity of dauer larvae. Recently, it was revealed that AMPK acts
on catalases and regulates the levels of H2O2 into the cell (Xie
and Roy, 2012). Similarly to ROS, sub-lethal doses of H2O2 sig-
nal to the nucleus through the HIF-1 transcription factor and
modulate the physiology of the cell enabling the survival under
stress. Some of the genes that are up-regulated favor the biosyn-
thesis of fatty acids. In parallel, H2O2 blocks lipases and protects
lipid stores. Moreover, AMPK modulates autophagy through the
direct phosphorylation of ULK1, the mammalian ortholog of
Atg1, as a required step for survival when nutrients are insufﬁcient
(see next paragraph and Lee et al., 2010a; Egan et al., 2011; Kim
et al., 2011).
Although it is currently unknownwhether othermitochondria-
to-nucleus signals are engaged in insulin/IGF-1 deﬁcient organ-
isms, the regulation of mitochondrial respiration is clearly a
key component of lifespan extension and can further inﬂuence
survival. As an example, increased mitochondrial fusion, by sup-
pressing dynamin-related protein DRP-1 expression does not alter
the lifespan of wild-type animals, whereas it further prolongs the
survival of daf-2 mutant nematodes (Yang et al., 2011). Similarly,
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FIGURE 1 | Longevity pathways.The insulin/IGF-1 signaling, theTOR
signaling and the molecular cascade that is activated by mild mitochondrial
dysfunction are three important pathways that interact with each other and
modulate aging in various organisms. The crosstalk between these pathways
is represented in the ﬁgure. Arrows indicate positive regulatory events and
red bars indicate inhibitory interactions. Dotted arrows or bars represent
interactions between the different pathways, whereas dashed arrows or
double bars indicate possible indirect interactions. AGE-1/PI3K,
phospatidylinositol-3-kinase; DAF-16/FOXO, forkhead box O (FOXO)
transcription factor; HSF-1, heat shock response transcription factor-1;
SKN-1/Nrf, skin in excess transcription factor 1/NF-E2-related factor; TSC1/2,
tuberous sclerosis complexes 1 and 2; RHEB, Ras homolog enriched in brain;
TOR, target of rapamycin kinase; S6K, S6 kinase; 4E-BP1, eukaryotic initiation
factor 4E-binding protein; PHA-4/FOXA, forkhead box A (FOXA) transcription
factor; ROS, reactive oxygen species; ATP, adenosine-5′-triphosphate;
CEH-23, homeobox transcription factor; HIF-1, hypoxia-inducible transcription
factor 1; AMPK, adenosine monophosphate-activated protein kinase; ULK-1/
Atg1, serine-threonine kinase ortholog of the autophagy related kinase 1 (Atg1).
increased mitochondrial proliferation in insulin/IGF-1 deﬁcient
animals as a result of some genetic lesions, like prohibitins, causes
a twist in cellular metabolism and further extends the lifespan of
nematodes (Artal-Sanz and Tavernarakis, 2009).
THE TOR SIGNALING PATHWAY
The serine/threonine kinase “target of rapamycin” TOR (mTOR
in mammals) has drawn large attention for its pleiotropic effects
on aging through the control of multiple downstream pathways
(Ravikumar et al., 2010; Figure 1). TOR senses the availability of
amino acids and nutrients into the cell and regulates cell growth,
proliferation, and metabolism accordingly. In the presence of
growth factors, like insulin and IGF-1, Akt kinase is activated
and controls the function of the TSC1/TSC2 complex, a neg-
ative regulator of mTOR. Post developmental TOR inhibition
extends the lifespan of many different organisms, ranging from
yeast to mammals (Vellai et al., 2003; Jia et al., 2004; Kapahi
et al., 2004; Kaeberlein et al., 2005; Harrison et al., 2009). More-
over, TOR mediates gene transcription that, at least in yeast
and in C. elegans, is necessary for the effect on chronological
lifespan (Medvedik et al., 2007; Sheaffer et al., 2008). In yeast,
TOR increases the expression of the nicotinamidase gene PNC1,
an important regulator of the NAD-dependent deacetylase Sir2,
through the transcription factors Msn2p and Msn4p (Medvedik
et al., 2007). In C. elegans, reduced TOR signaling enables the
forkhead transcription factor PHA-4 to induce the expression
of pro-survival factors that contribute to lifespan extension of
animals under nutrient restriction (Sheaffer et al., 2008). In a
variety of conditions, TOR signaling controls the expression of
stress-resistance genes through the SKN-1/Nrf transcription fac-
tor and prevents the ROS formation beyond a fatal threshold due
to the increased mitochondrial metabolism (Robida-Stubbs et al.,
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2012; Zarse et al., 2012). In mammals, decreased mTOR activity,
due to rapamycin, prevents the direct binding and coactivation
of the transcription factor ying-yang 1 (YY1) with the peroxi-
some proliferator-activated receptor gamma coactivator 1-alpha
(PGC-1α). At the molecular level, disruption of this complex
and reduced recruitment to the promoters of genes encod-
ing mitochondrial proteins diminishes mitochondrial biogenes-
is and consequently oxidative phosphorylation (Cunningham
et al., 2007).
Beside the regulation of gene expression, TOR pathway con-
tributes to aging through its role in protein synthesis: TOR
activates the ribosomal subunit S6 kinase (RS6K) and in parallel
inhibits the 4E-BP1, which is a negative regulator of transla-
tion, resulting in increased protein synthesis. Block of protein
synthesis through inhibition of RS6K or the initiation of trans-
lation 4E protein (eIF4E), which is the target of 4E-BP inhibitor,
leads to lifespan extension in various organisms (Kapahi et al.,
2004; Kaeberlein et al., 2005; Hansen et al., 2007; Pan et al.,
2007; Syntichaki et al., 2007; Selman et al., 2009). In S6K knock-
out mice they have found activation of pathways regulated by
PGC-1α and AMPK in some tissues, like the liver, adipose tis-
sue, or muscles (Selman et al., 2009). These pathways modulate
mitochondrial biogenesis. In yeast, Sch9/S6K regulates mitochon-
drial oxygen consumption and mutant strains, either for TOR
or Sch9/S6K, up-regulate both nuclear and mitochondrial genes
encoding proteins of oxidative phosphorylation (OXPHOS; Pan
and Shadel, 2009). In ﬂies kept under dietary restriction (DR),
the 4E-BP boosts mitochondrial activity due to enhanced transla-
tion of nuclear-encoded mitochondrial genes, whereas inhibition
of the electron transport chain prevents the lifespan extension
(Zid et al., 2009).
By all means, the integration of the cellular status depends on
the crosstalk between the different pathways and intracellular sen-
sors. Nutrient or growth factor deprivation promotes the catabolic
process autophagy through TOR. Autophagy is a homeostatic
process likely developed in unicellular organisms as an adaptive
survival response to harsh conditions (Yorimitsu and Klionsky,
2005; Singh and Cuervo, 2011). It is important for the turnover
of intracellular macromolecules and damaged organelles and, it
is widely considered as a potential anti-aging mechanism. Thus,
in the case of mitochondria, TOR not only regulates mitochon-
drial biogenesis but also regulates mitochondrial turnover though
macroautophagy (mitophagy). During this process the cytosolic
material is engulfed by double-membrane vesicles and targeted to
the lysosome for degradation. This quality control mechanism
protects from the intracellular accumulation of dysfunctional
organelles and, therefore, from eventual oxidative stress as a
result of inefﬁcient oxidative phosphorylation. TOR modulates
autophagy through a cascade of events that alters the phospho-
rylation status of the serine/threonine kinases ULK-1/ULK-2,
the mammalian orthologs of Atg1, and the association between
Ambra1 and Beclin-1, favoring the recruitment of autophagy-
related proteins to the nascent phagophore (Rubinsztein et al.,
2011). Notably, reduction of TOR activity increases autophagy,
which is required for the lifespan extension in TOR-deﬁcient
animals and insulin/IGF-1 defective mutants (Vellai et al., 2003;
Hansen et al., 2008; Toth et al., 2008; Bjedov et al., 2010). According
to this view, block of autophagy abolishes the extension of lifes-
pan in the daf-2 mutants independently of the DAF-16/FOXO
transcription factor, although with a less pronounced effect com-
pared to daf-16 loss-of-function (Melendez et al., 2003; Hansen
et al., 2008). Possibly, enhanced autophagy promotes longevity
only in those conditions in which the engagement of the nuclear
expressionmachinery directs rawmaterial deriving from catabolic
processes to newly synthesized biomolecules. The role of TOR
pathway in aging is further supported by studies showing that
the TOR inhibitor rapamycin prolongs the lifespan of different
organisms through changes in the protein synthesis and autophagy
(Kapahi et al., 2004; Kaeberlein et al., 2005; Hansen et al., 2008;
Toth et al., 2008; Harrison et al., 2009; Bjedov et al., 2010). Inter-
estingly, rapamycin treatment protects from some age-related
pathologies, such as cancer, and extends the lifespan of mice,
even when the feeding begins during adulthood. This might lead
to the development of pharmacological interventions targeting
mTOR signaling, which could theoretically delay some of the age-
related phenotypes and prevent age-related disorders (Harrison
et al., 2009).
MITOCHONDRIAL DEFICIENCY AND OXIDATIVE STRESS
One of the ﬁrst and most accepted aging theories, called the “free
radical theory of aging,” proposes that loss of protective mech-
anisms and enhanced ROS-dependent macromolecule’s damage
create a vicious cycle that leads to progressive deterioration of
the intracellular systems (Harman, 1956). At the cellular level,
insufﬁcient handling of oxidative stress induces senescence and
ultimately death. According to this theory, mitochondria con-
tribute as the main source of intracellular ROS, which then cause
age-related decline of respiration through damage of the ETC
subunits (Kirkwood, 2005). The gradual leakage of the mitochon-
drial electron transport system is the main endogenous source
of reactive radicals that sustains this deleterious feedback loop.
In addition, as a consequence of uncontrolled oxidative stress,
mitochondrial DNA (mtDNA) accumulates many mutations or
deletions. Interestingly, studies in cell lines have revealed thatmito-
chondria with impaired ETC or mtDNA mutations can produce
even more ROS further increasing the ROS overload of the cell
(Indo et al., 2007). Other studies have shown that mutations in
the mtDNA accumulate during aging and, at least in mice, can
accelerate certain age-related phenotypes (Melov et al., 1995a,b;
Welle et al., 2003). However, whether mtDNA mutations are the
cause or the consequence of aging is still a matter of debate. In
a mouse model expressing an error-prone version of the cat-
alytic subunit of themtDNApolymerase, accumulationofmtDNA
mutations leads to respiratory dysfunction and premature aging
(Trifunovic et al., 2004). Interestingly, these animals do not show
increased ROS production indicating that their accelerated aging
might be linked to respiratory deﬁciency rather than oxidative
stress (Trifunovic et al., 2005). In line with these observations, the
use of vitamins, natural antioxidants, does not have any effect in
the life expectancy in humans (Bjelakovic et al., 2008; Chong-Han,
2010). Even more intriguing is the fact that nematode mutants
for the superoxide dismutase (SOD) genes show prolonged rather
than decreased lifespan, despite the signiﬁcant oxidative damage
(Van Raamsdonk and Hekimi, 2009). All these indications raise
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questions whether oxidative stress is themain cause of aging or it is
simply the result of extended mitochondrial dysfunction (Hekimi
et al., 2011).
MITOCHONDRIAL FUNCTION AND AGING:
HOW TO LIVE LONGER
Efﬁcient oxidative phosphorylation is critical for the normal cel-
lular function as it provides most of the intracellular energy.
Paradoxically, slight mitochondrial dysfunction exerts a beneﬁcial
effect on the lifespan inmanyorganisms. Indeed,RNA interference
(RNAi) or mutations in genes encoding certain subunits of the
electron transport chain (ETC) cause mild mitochondrial defect
and promote longevity. One example is the clk-1 gene encod-
ing a mitochondrial hydroxylase necessary for the ubiquinone
biosynthesis and therefore important for an effective ETC. Both
in C. elegans and in mice, mutation or haploinsufﬁciency of clk-1
decreases the oxidative phosphorylation rate and prolongs sig-
niﬁcantly the lifespan (Lakowski and Hekimi, 1996; Felkai et al.,
1999; Liu et al., 2005). In nematodes, mitochondrial deﬁciency
is associated with a delayed developmental rate, reduced adult
size, and lower fecundity. The lifespan extension requires AMPK
activity and the engagement of autophagy, whereas it is indepen-
dent of the insulin/IGF-1 signaling pathway (Curtis et al., 2006;
Toth et al., 2008; Figure 1). Longevity is also increased by alter-
ing mitochondrial function through silencing of genes encoding
other mitochondrial proteins beside the ETC, as long as the treat-
ments occur during development (Felkai et al., 1999; Dillin et al.,
2002; Lee et al., 2003). However, null mutations in genes encoding
ETC components severely compromise survival. Taken together,
mitochondrial dysfunction can improve the ﬁtness and survival
of an organism up to a certain threshold beyond which toxicity
is reached and viability is compromised (Figure 2). Even when
restricted to a single tissue, like the intestine or the nervous sys-
tem, mitochondrial dysfunction can extend the lifespan of the
whole organism (Durieux et al., 2011). According to this model,
mitochondrial stress in a limited number of cells is sufﬁciently
sensed by surrounding tissues and modulates aging in a cell-non-
autonomous manner. Although the pro-longevity signals remain
to be identiﬁed, it is not excluded that ROS take part in the process,
as antioxidants can limit this phenotype. Mitochondrial deﬁciency
can engage protective pathways through gene transcription. In the
case of long-lived animals, increased levels of ROS, along with
decreased mitochondrial respiration, is sufﬁcient to activate tran-
scription factors, such as SKN-1 (An andBlackwell, 2003),CEH-23
(Walter et al., 2011), andHIF-1 (Lee et al., 2010b), thatmediate the
transcription of antioxidant enzymes like SOD, catalase, and glu-
tathione transferase (Figure 1). These detoxifying enzymes can
maintain the ROS levels below a certain threshold, protecting the
cellular structures from extensive damage. This type of retrograde
signaling is called mitochondrial hormesis (Ristow and Zarse,
2010) and is in accordancewith the basic concept that the exposure
of an organism to mild stress results in an adaptive or hormetic
response (Calabrese and Baldwin, 2002). Beside the increased
resistance to stress, another possible scenario might include the
engagement of alternativemetabolic pathways that sustain cellular
functions (Liu and Butow, 2006). In support of this hypothesis, it
has been found that activated AMPK induces the phosphorylation
FIGURE 2 | Mitochondrial dysfunction in aging and
neurodegeneration. Mitochondrial dysfunction can have either a positive
or a negative effect on the normal function of the cell; mild mitochondrial
dysfunction stimulates retrograde signaling, increasing – among others –
the production of antioxidant enzymes and inducing metabolic changes.
This adaptive response leads to the extension of the lifespan of the
organism. On the contrary, severe disturbance of the mitochondrial activity
may become detrimental for the survival of the cell, as it compromises
energy production, induces oxidative stress and disturbs calcium
homeostasis. Under these conditions, neurons undergo rapid changes of
the dendritic structures and, according to the damage, can engage
detrimental programs that cause cell death. Thus, strong mitochondrial
inefﬁciency may lead to the development of neurodegenerative diseases.
of DAF-16/FOXO and CHR-1/CREB in nematodes, mediating the
expression of genes involved in metabolism and energy home-
ostasis (Greer et al., 2007b; Mair et al., 2011). In conclusion,
similarly to other pro-longevity signaling pathways, mitochon-
drial deﬁciency could stimulate gene expression and change the
consequent transcriptional proﬁles in response to altered ETC
efﬁciency.
MITOCHONDRIAL FUNCTION AND NEURODEGENERATION:
A DELICATE BALANCE THAT CAN KILL
Mitochondria take part in a variety of heterogeneous intracellu-
lar processes. Speciﬁcally, they provide most of the cellular ATP
through oxidative phosphorylation, produce ROS as side prod-
ucts, contribute to intracellular calcium homeostasis and under
certain conditions, they can activate speciﬁc cell death programs.
In neuronal cells, the abundance of mitochondria in subdomains
critically regulates the density of dendritic structures, contribut-
ing to synaptic plasticity. Impairment of mitochondrial dynamics
at the dendrites negatively affects the formation of new spines
and leads to loss of synapses (Li et al., 2004). As it is expected,
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decline of the mitochondrial activity over time can progressively
perturb the intracellular environment and affect the maintenance
of the surrounding tissues. Thus, it is not surprising that aging
and neurodegeneration are strongly linked with mitochondrial
defects. However, at which rate mitochondrial activity enables
survival and, conversely, at which degree compromised organelles
cause irreversible damage remain two fascinating open questions.
This possible double-edged sword aspect is of particular interest
as mitochondria have apparently an opposite role in these two
biological processes: while their severe dysfunction provokes neu-
rodegeneration, a slight decrease in respiration extends the lifespan
in a range of organisms as diverse as yeast, invertebrates, and
mammals (Figure 2). Whether the engagement of pro-survival
programs, including those activated by slight mitochondrial deﬁ-
ciency, can have any protective effect in brain disorders remains
still unclear.
As previously shown in animals models, the use of inhibitors of
themitochondrial respiratory complexes induces neuronal degen-
eration in certain brain regions and therefore resembles certain
types of pathologies. For example, the use of the neurotoxins
rotenone and MPTP, which mainly act at the level of the Com-
plex I, triggers the loss of dopaminergic neurons and causes
symptoms similar to the sporadic forms of Parkinson’s disease
(Gerlach et al., 1991; Panov et al., 2005). Similarly, the succinate
dehydrogenase inhibitor 3-nitropropionic acid triggers extensive
neurodegeneration in the striatum and has been used to model
Huntington’s disease (Brouillet et al., 1999). In support of the
mitochondrial role in brain disorders, a large number of studies
havedemonstrated a signiﬁcant associationbetween familial forms
of neurodegenerative diseases and rare mutations in genes encod-
ing proteins related to mitochondria. Interestingly, almost one
third of the mutations that are linked to brain pathologies affect
proteins required for the normal mitochondrial functions (Schon
and Przedborski, 2011; Exner et al., 2012). Although Alzheimer’s,
Parkinson’s and other neurodegenerative diseases are frequently
described as age-related pathologies without any genetic linkage
andwith distinct clinical symptoms, they all share commondegen-
erative mechanisms that converge onmitochondria. Most of these
diseases exhibit metabolic defects and increased oxidative stress.
For example, in Alzheimer’s disease (AD) there are signiﬁcant
changes in mitochondrial morphology and number (Hirai et al.,
2001; Baloyannis, 2006), which are associated with reduced levels
of some of the ETC subunits. Besides providing ATP, mitochon-
dria sense localized Ca2+ changes and prevent the build-up of
excessive intracellular Ca2+ that can trigger death programs. In a
variety of neurodegenerative disorders, accumulationof glutamate
at the synaptic cleft leads to prolonged neuronal depolarization
and, through intracellular and plasmamembraneCa2+ permeable
channels, large Ca2+ inﬂux (Bano and Nicotera, 2007; Moskowitz
et al., 2010). The sustained mitochondrial Ca2+ uptake leads to
extensive mitochondrial depolarization and release of pro-death
factors, which then promote caspase-dependent and independent
cell death according to the intensity of the stimulus (Ankarcrona
et al., 1995; Orrenius et al., 2003). Notably, at least in vitro, uncou-
pling of themitochondrial ETC signiﬁcantly reduces cell death as a
result of the excitotoxic Ca2+ overload (Budd andNicholls, 1996).
Thus, at least for a limited period of time, mild mitochondrial
dysfunction and time-limited collapse of the membrane poten-
tial can be protective against neurotoxins and favor neuronal
survival.
CAN LONGEVITY PATHWAYS CONFER NEUROPROTECTION?
Despite the large number of studies on aging in model organ-
isms, especially invertebrates, there is still an open question: can
pro-longevity pathways prevent brain disorders? Although more
work is required to prove the relevance in humans, new evidence
suggests that low insulin/IGF-1 signaling or decreased TOR sig-
naling has a beneﬁcial effect in aggregate-prone animal models
of neurodegenerative diseases. More speciﬁcally, Igf1r haploin-
sufﬁciency can reduce inﬂammatory response, neuronal loss and
cognitive impairment associatedwith toxicAβ aggregates inmouse
models of AD (Cohen and Dillin, 2008; Cohen et al., 2009; Freude
et al., 2009; Killick et al., 2009). Over time, decreased IGF-1 lev-
els promote the assembly of densely packed ﬁbrils that are less
toxic compared with Aβ oligomers. In line with this, activation
of the DAF-16/FOXO3a, one of the main downstream targets
of the insulin/IGF-1 signaling, either genetically – encoding a
nuclear targeted FOXO3a – or pharmacologically – using a spe-
ciﬁc compound called Psammaplysene A (PA) – protects both in
vitro and in vivo against insults causing motor neuron disease
(Mojsilovic-Petrovic et al., 2009). Similarly to the insulin/IGF-1
signaling pathway, long-term rapamycin treatment prevents cog-
nitive deﬁcits throughout the lifespan in mice (Ehninger et al.,
2009; Halloran et al., 2012). In an AD mouse model, rapamycin
improves learning and memory, ameliorates cognitive defects,
and slows or blocks the progression of the disease (Caccamo
et al., 2010; Spilman et al., 2010). However, even in wild type
mice, rapamycin seems to have a beneﬁcial effect in cognition,
since it can ameliorate learning and memory deﬁcits (Majumder
et al., 2012). In another interesting study, it was found that
the oral administration of the natural polyphenol resveratrol in
mice was enough to activate the metabolic sensor AMPK and
reduce the cerebral Abeta levels and their deposition in the cortex
(Vingtdeux et al., 2010).
Downregulation of the insulin/IGF-1 signaling pathway, in a
C. elegans model for Huntington’s disease delays dramatically the
polyQ toxicity and the protein aggregates and protects from neu-
rodegeneration (Morley et al., 2002). In accordance with this,mice
for Huntington’s disease harboring only one copy of the IRS2 – the
insulin receptor substrate that control the phosphorylation of the
downstream PI3K – have improved motor performance and live
longer compared with their littermates (Sadagurski et al., 2011).
Importantly, some of the ameliorated phenotypes are the result of
improved mitochondrial activity and decreased levels of oxidative
stress. Clioquinol is ametal chelator that has been extensively used
as a neuroprotective drug in Alzheimer’s, Parkinson’s, and Hunt-
ington’s models or even as a drug in patients, where it reduces the
accumulation or the expression of the toxic proteins (Cherny et al.,
2001; Kaur et al., 2003; Nguyen et al., 2005). This drug inhibits the
activity of CLK-1, a mitochondrial protein, and mimics many of
the phenotypes produced by reduction of its activity in nematodes
andmice. Thismight indicate that clioquinol acts, at least partially,
through the mitochondrial pathway that affects longevity (Wang
et al., 2009).
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Insulin/IGF-1 signaling + ? YES
TOR pathway + ? YES
Mitochondria + + ?
Insulin/IGF-1 andTOR signaling pathways are two of the main longevity determi-
nants, whose downregulation not only increases the lifespan but also protects
from neurodegenerative insults. Mitochondrial function is critical both for aging
and neurodegeneration: mild dysfunction is beneﬁcial and increases the lifespan
of the organism, whereas a sustained deregulation leads to cell death.
Taken together, these ﬁndings demonstrate that genetic and
pharmacological interventions that diminish thePI3K/Akt orTOR
signaling cascade can attenuate some of the damaging effects
associated with the expression of aggregate-prone peptides. As
part of the mechanism, the maintenance of mitochondrial activ-
ity and resistance to oxidative stress can delay neuronal loss in
animal models of human brain disorders. In principle, we can
predict the delay of at least some aspects of neurodegenerative
disorders by altering those signaling cascades that directly or indi-
rectly control mitochondrial activity and therefore regulate the
progression of aging in an organism. However, more studies
are required to prove the relevance of these ﬁndings in human
pathology (see Table 1).
CONCLUDING REMARKS
Over the last years, signiﬁcant progress was achieved in the ﬁeld
of aging and led to the identiﬁcation of molecular pathways
underlying this important biological process. Most of thesemolec-
ular pathways are evolutionarily conserved and affect various
tissues, including the central nervous system. This is reﬂected by
changes both in the morphology and the function of the neurons,
which can promote cognitive decline and the onset of neurode-
generative diseases. Interestingly, some of the mechanisms that
regulate aging are linked to neurodegeneration.
Mitochondrial activity signiﬁcantly contributes to aging and
plays amajor role inneurodegeneration. However, these organelles
inﬂuence in an opposite way these processes: severemitochondrial
dysfunction triggers neurodegeneration and affects animal sur-
vival (Gerlach et al., 1991; Kong and Xu, 1998; Panov et al., 2005;
Keeney et al., 2006), whereasmildmitochondrial dysfunction pro-
longs the lifespan of various organisms through broad metabolic
changes and the build-up of protective defenses against stress-
ful conditions (Wong et al., 1995; Feng et al., 2001; Dillin et al.,
2002; Lee et al., 2003; Liu et al., 2005; Dell’agnello et al., 2007;
Copeland et al., 2009). Nevertheless, there are still many open
questions that must be addressed. For example, what is the limit
beyond whichmitochondrial deﬁciency causes cell death? Is mito-
chondrial activity a good anti-aging target? Can modulation of
mitochondrial function prolong life expectancy without causing
neurodegeneration? The better understanding of the molecu-
lar mechanisms underlying aging might offer opportunities to
improve healthy human lifespan and in parallel to provide new
therapeutic strategies for brain disorders.
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